IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Palo Alto Investors LP

Q3 2022 Holdings

Filed 2022-11-14 | 32 holdings | $307.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$167.5M1,976,26554.4%
Biogen Inc(BIIB)COM09062X103$96.4M360,98131.3%
Acadia Pharmaceuticals Inc(ACAD)COM004225108$27.5M1,678,1968.9%
Align Technology Inc(ALGN)COM016255101$9.2M44,3053.0%
Cytokinetics Inc(CYTK)COM23282W605$5.4M111,7171.8%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$859.0K160,8000.3%
United Therapeutics Corp(UTHR)COM91307C102$132.6K633,5340.0%
Insmed Inc(INSM)COM457669307$125.8K5,840,3980.0%
Abiomed Inc(ABMDEUR)COM003654100$120.6K490,7540.0%
Revance Therapeutics Inc(RVNCEUR)COM761330109$118.9K4,405,0390.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$102.8K9,847,7740.0%
Prothena Corp PLC(PRTA)COMG72800108$100.0K1,649,7770.0%
Staar Surgical Co(STAA)COM852312305$77.4K1,096,8820.0%
Sage Therapeutics Inc(SG7)COM78667J108$33.3K851,4090.0%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$30.7K5,621,5330.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$21.4K2,166,1560.0%
Gossamer BIO Inc(GOSS)COM38341P102$21.0K1,750,6510.0%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$14.7K612,6000.0%
Alkermes PLC(ALKS)COMG01767105$13.5K603,4000.0%
Anaptysbio Inc(ANAB)COM032724106$11.0K431,0240.0%
Ehealth Inc(EHTH)COM28238P109$7.7K1,977,9930.0%
Gritstone Oncology Inc(2JQ)COM39868T105$6.0K2,330,5040.0%
Kezar Life Sciences IncCOM49372L100$5.7K656,2000.0%
Clovis Oncology Inc(CLVSEUR)COM189464100$5.3K4,473,9670.0%
Travere Therapeutics Inc(TVTX)COM89422G107$4.1K166,0690.0%
Provention BIO Inc(PRVBUSD)COM74374N102$1.8K390,8000.0%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$1.4K64,7000.0%
Alimera Sciences IncCOM016259202$1.0K200,9190.0%
Magenta Therapeutics IncCOM55910K108$610432,3000.0%
Tactile Systems Technology I(TCMD)COM87357P100$21127,1000.0%
Marinus Pharmaceuticals Inc(MRNS*)COM56854Q200$20831,3300.0%
Urogen Pharma LTD(URGN)COMM96088105$20424,5000.0%